Gene therapy for muscular dystrophy is a promising treatment strategy because it has the potential to restore dystrophin expression in dystrophic muscle, and thereby improve muscle function and stabilize disease progression in all DMD patients regardless of the nature of their genetic mutations. The gene discussed is DMD; the disease is Duchenne muscular dystrophy.